FindTrial
Sign In

A prospective study of pessaries for pelvic organ prolapse: long-term follow-up outcomes and the changes in 3D ultrasonography

Production and application of the genetic engineered patch loaded with sheep muscle-derived stem cells (MDSC) in the treatment of pelvic organ prolapse

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17011237
Enrollment
Unknown
Registered
2017-04-24
Start date
2017-06-01
Completion date
Unknown
Last updated
2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic organ prolapse

Interventions

pessary group:using pessary

Sponsors

Shaanxi Provincial People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: patients who have symptomatic POP with or without stress urinary incontinence (SUI) or overactive bladder syndrome (OAB), and patients who desired non-surgical management, or are too frail for surgery.

Exclusion criteria

Exclusion criteria: patients with active pelvic infection or severe ulceration, allergy to both silicone and latex, or those patients who are non-compliant and unlikely to follow up.

Design outcomes

Primary

MeasureTime frame
POP-Q;syndrom of bladder;syndrome of rectum;—

Countries

China

Contacts

Public ContactLi bin

Shaanxi Provincial People's Hospital

echo85535063@163.com+86 15229334369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026